Immune adjuvant and vaccine composition including the same
AssigneeRepublic of Korea (Animal and Plant Quarantine Agency)
InventorsMinja Lee, Hyundong Jo, Su-Mi Kim, Byounghan Kim, Jong-Hyeon Park
Life of this patent
Estimating the term…
Loading patent…
AssigneeRepublic of Korea (Animal and Plant Quarantine Agency)
InventorsMinja Lee, Hyundong Jo, Su-Mi Kim, Byounghan Kim, Jong-Hyeon Park
Estimating the term…
The present inventors have found that innate immune response and T cell exhaustion pathway are more greatly over-expressed in pigs than cattle, such that the pigs are less likely to form adaptive and humoral immune responses than cattle. It would be suggested herein an innovative strategy for improvement of abnormal immune responses in pigs by simultaneously inducing potent cellular and humoral immune responses and applying T cell agonists as a new vaccine adjuvant. This result may provide an important clue for understanding a difference in the immune response between the cattle and pigs, while suggesting a method for maximizing the immune response and vaccine efficacy, which are less expressed in pigs than cattle.
A foot-and-mouth disease (FMD) vaccine composition comprising an adjuvant composition, wherein the adjuvant composition comprises any one or more selected from the group consisting of γδ T cell agonist, MAIT cell agonist, and T cell agonist, as an active ingredient,
Dependencies are inferred from the claim text.